Trademark: CASILIO 2102106
Word
CASILIO
ID
2102106
Trademark Type
WORD
Status
Protected: Registered/protected
Application Date
04 June 2020
Registration Date
04 June 2020
Renewal Date
04 June 2030
Owner(s)
Service
Davies Collison Cave Pty Ltd
Goods and Services:
Class 42:
Scientific research and development, namely, gene modification, including gene regulation and gene editing, for researching and developing modified mammalian and human cells and pharmaceuticals; research and development of therapeutics and pharmaceuticals using gene modification and gene editing technologies; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals.
Scientific research and development, namely, gene modification, including gene regulation and gene editing, for researching and developing modified mammalian and human cells and pharmaceuticals; research and development of therapeutics and pharmaceuticals using gene modification and gene editing technologies; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals.